Tech Company Financing Transactions
Cadence Pharmaceuticals Funding Round
On 6/30/2005, Cadence Pharmaceuticals secured $13.8 million in investment from CDIB Bioscience, Domain Associates and ProQuest Investments.
Transaction Overview
Company Name
Announced On
6/30/2005
Transaction Type
Venture Equity
Amount
$13,800,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12481 High Bluff Dr. 200
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Theodore Schroeder
Chief Financial Officer
William LaRue
VP - General Counsel
Hazel Aker
VP - Human Resources
Diane Sheehan
VP - Regulatory Affairs
Malcolm Smith
VP - Sales
Scott Byrd
Browse more venture capital transactions:
Prev: 6/30/2005: Tello venture capital transaction
Next: 6/30/2005: Neotropix venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs